Table 4.
IL-6 (pg/mL) | TNF-α (pg/mL) | Leptin (ng/mL) | Adiponectin (μg/mL) | oxLDL (U/l) | OxLDL/LDL (U/mmoL) | OxLDL/HDL (U/mmoL) | CRP (mg/L) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Rho | P | Rho | P | Rho | P | Rho | P | Rho | P | Rho | P | Rho | P | Rho | P | |
Anthropometric indices | ||||||||||||||||
BMI (kg/m2) | 0.427 | 0.001 | 0.305 | 0.032 | 0.200 | 0.033 | 0.464 | <0.001 | ||||||||
WC (cm) | 0.424 | 0.003 | 0.239 | 0.010 | 0.234 | <0.001 | ||||||||||
Body fat (%) | 0.527 | <0.001 | 0.503 | <0.001 | 0.429 | <0.001 | ||||||||||
FFM (kg) | 0.247 | 0.010 | ||||||||||||||
TBW (kg) | 0.195 | 0.044 | 0.296 | 0.002 | ||||||||||||
VFL | 0.526 | <0.001 | 0.391 | <0.001 | 0.257 | 0.009 | ||||||||||
Biochemical markers | ||||||||||||||||
Glucose (mg/dl) | 0.463 | 0.002 | 0.280 | 0.003 | ||||||||||||
Insulin (μIU/mL) | 0.257 | 0.008 | 0.254 | 0.009 | ||||||||||||
ΤC (mg/dl) | 0.534 | <0.001 | -0.301 | 0.001 | 0.322 | <0.001 | ||||||||||
TG (mg/dl) | 0.483 | <0.001 | ||||||||||||||
HDL (mg/dl) | -0.309 | 0.035 | -0.191 | 0.041 | -0.557 | <0.001 | ||||||||||
LDL (mg/dl) | 0.493 | <0.001 | -0.341 | <0.001 | 0.351 | <0.001 | ||||||||||
SGOT (iu/l) | -0.339 | 0.026 | ||||||||||||||
SGPT (iu/l) | -0.518 | <0.001 | ||||||||||||||
γ-GT (iu/l) | -0.444 | 0.003 | ||||||||||||||
ALP (U/L) | 0.261 | 0.006 | ||||||||||||||
Quality of life questionnaires | ||||||||||||||||
AIS | 0.354 | 0.027 | 0.367 | 0.025 | ||||||||||||
CESD-R | 0.364 | 0.041 | 0.391 | 0.022 | ||||||||||||
RSES | -0.545 | 0.002 | -0.441 | 0.017 | ||||||||||||
PCS-12 | -0.517 | 0.002 | 0.497 | 0.004 |
IL-6, interleukin-6; TNF-α, tumor necrosis factor-α; oxLDL, oxidized low density lipoprotein; CRP, C-reactive protein; BMI, body mass index; WC, waist circumference; FFM, free fat mass; VFL, visceral fat level; TC, total cholesterol; TG, triglycerides; HDL, high density lipoprotein; LDL, low density lipoprotein; SGOT, serum glutamic-oxaloacetic transaminase; SGPT, serum glutamic-pyruvic transaminase; γ-GT, γ-glutamyl transferase; ALP, alkaline phosphatase; AIS, Athens Insomnia Scale; CESD-R, Center for Epidemiologic Studies Depression Scale Revised; RSES, Rosenberg Self-Esteem scale; PCS-12, Physical Component Score. Correlation analysis was performed with Spearman’s rank correlation. Level of significance was set as 0.05. Significant p are in bold.